Employment Opportunities

As active investors in seed and early stage biotechnology companies we are always looking for individuals who are or aspire to be CEO's with relevant experience for start-up / early stage Life Science companies.

Please contact us at info@avlar.com

Portfolio News

18 April 2008
Intercytex plc: funding award from US Government

10 April 2008
Recommended Acquisition of CENES PHARMACEUTICALS PLC by PAION AG

10 April 2008
CeNeS Pharmaceuticals plc proposed acquisition by PAION AG

All Portfolio News

News Archive
2004 News Archive

Weather in Cambridge

Temp: N/A ºF

Last Updated: N/A

Our Investors

3i

Access Capital Partners

Astellas Venture Capital

Avlar management

BTG

Cambridge University

Coller Capital

European Investment Fund

Lloyds TSB DC

Lexington Partners Inc

Preferred Advisors

Morrison & Foerster MNP

Opportunities

CEOs with relevant experience for start-up / early stage Life Science companies.

Privacy Statement | Sitemap | © 2008 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.